Quote | SciSparc Ltd Ord (OTCMKTS:SPRCF)
Last: | $6.70 |
---|---|
Change Percent: | -2.05% |
Open: | $6.4075 |
Close: | $6.70 |
High: | $6.84 |
Low: | $6.4075 |
Volume: | 9,104 |
Last Trade Date Time: | 12/21/2021 04:54:46 pm |
News | SciSparc Ltd Ord (OTCMKTS:SPRCF)
SciSparc Provides Updates Upon Conclusion of 2021 PR Newswire TEL AVIV, Israel , Dec. 29, 2021 /PRNewswire/ -- SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the cent...
SciSparc's Ordinary Shares to Commence Trading on Nasdaq Capital Market Today PR Newswire TEL AVIV, Israel , Dec. 22, 2021 /PRNewswire/ -- SciSparc Ltd. (NASDAQ: SPRC) a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to ...
Message Board Posts | SciSparc Ltd Ord (OTCMKTS:SPRCF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
SciSparc Ltd Ord Company Name:
SPRCF Stock Symbol:
OTCMKTS Market:
SciSparc Provides Updates Upon Conclusion of 2021 PR Newswire TEL AVIV, Israel , Dec. 29, 2021 /PRNewswire/ -- SciSparc Ltd. (NASDAQ: SPRC), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the cent...
SciSparc's Ordinary Shares to Commence Trading on Nasdaq Capital Market Today PR Newswire TEL AVIV, Israel , Dec. 22, 2021 /PRNewswire/ -- SciSparc Ltd. (NASDAQ: SPRC) a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to ...
SciSparc Announces Approval of Uplisting to The Nasdaq Capital Market PR Newswire TEL AVIV, Israel , Dec. 20, 2021 /PRNewswire/ -- SciSparc Ltd. (OTCQB: SPRCF) a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat di...